Entinostat

CAS No. 209783-80-2

Entinostat ( MS-275;SNDX-275;MS 275;SNDX 275 )

Catalog No. M13310 CAS No. 209783-80-2

A potent and selective class I HDACs inhibitor with IC50 of 243/453/248 nM for HDAC1/2/3.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 45 In Stock
25MG 65 In Stock
50MG 81 In Stock
100MG 113 In Stock
200MG 174 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Entinostat
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective class I HDACs inhibitor with IC50 of 243/453/248 nM for HDAC1/2/3.
  • Description
    A potent and selective class I HDACs inhibitor with IC50 of 243/453/248 nM for HDAC1/2/3; no inhibition on HDAC8/4/5/7/9/6/10 (IC50>10 uM); induces accumulation of p21WAF1/CIP1 and gelsolin in K562 cell; reduce S-phase cells and induce G1-phase cells in A2780 cell.Breast Cancer Phase 3 Clinical
  • Synonyms
    MS-275;SNDX-275;MS 275;SNDX 275
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC1;HDAC3
  • Research Area
    Cancer
  • Indication
    Breast Cancer

Chemical Information

  • CAS Number
    209783-80-2
  • Formula Weight
    376.41
  • Molecular Formula
    C21H20N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(OCC1=CC=CN=C1)NCC2=CC=C(C(NC3=CC=CC=C3N)=O)C=C2
  • Chemical Name
    Carbamic acid, N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-, 3-pyridinylmethyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Saito A, et al. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4592-7.
2. Lauffer BE, et al. J Biol Chem. 2013 Sep 13;288(37):26926-43.
3. Rosato RR, et al. Cancer Res, 2003, 63(13), 3637-3645.
molnova catalog
related products
  • SBHA

    SBHA (suberohydroxamic acid) is a Histone deacetylase (HDAC) inhibitor. HDAC is required for transcriptional modulation, cell cycle regulation and development.

  • Givinostat

    Givinostat or gavinostat, aslo known as ITF2357, is a potent and orally active histone deacetylase inhibitor with potential anti-inflammatory, anti-angiogenic, and antineoplastic activities.

  • T326

    A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM.